Claya Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.6/10
Best for: compounded semaglutide at $299/month
Claya's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked June 2026
Claya lists injectable semaglutide at $179 for the first month, after which refills lock at $299/month. It sells compounded semaglutide and tirzepatide in both injectable and oral-tablet form, a wider format range than most competitors. The site publicly names its clinicians and its two compounding pharmacy partners, and includes a weight-loss money-back guarantee and free expedited shipping.
Is Claya legit?
Yes. Claya is a real, operating US company, and we found no FDA warning letters issued to it. It says its medication comes from accredited compounding pharmacies (503A, 503B or PCAB). We rate it 6.6/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Claya promo or coupon code?
Claya publishes the code 100CLAYA (Code 100CLAYA: $100 off your first month (GLP-1 from $149/mo)). You enter it at checkout on Claya's own site. Other codes for Claya circulate on coupon sites, and we cannot vouch for those.
See how Claya compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Claya
Trimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Claya at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $179/mo
- What's included
- Medication · Shipping
- FDA status
- No FDA warning letters found
How Claya scores
Six columns, each one computed from something Claya has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
3.7/10$299/month is 20% above the $250 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
6.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
4.5/10The price covers the medication and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Claya
Last checked June 2026- Checked the listed price across 6 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Claya
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Claya involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Claya shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Claya which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication and shipping.
- Lowest ongoing monthly price: semaglutide $299, tirzepatide $299. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that Claya serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Claya
- Claya offers email support
Cancelling Claya
Taken from the terms Claya publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None
- Refund policy
- Money-back guarantee
- Early-termination fee
- None
GLP-1 medications Claya offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Check the price yourself before you pay
Every figure here was read off Claya's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication and shipping
- We found no FDA warning letters issued to Claya
Against it
- Semaglutide costs $299 a month, 62% above the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $299 a month, 20% above the $250 median for compounded tirzepatide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Claya charges
The standing price at Claya is $179/month.
- Compounded semaglutide: $179/month
- Compounded semaglutide: $299/month
- Oral semaglutide: $279/month
- Compounded tirzepatide: $279/month
- Compounded tirzepatide: $299/month
- Oral tirzepatide: $379/month
For compounded tirzepatide, the median across the sellers we compare is $250/month, so Claya's $299 is a premium, and a premium has to buy something. Check what is bundled before you accept it.
DudeMeds dispenses semaglutide and tirzepatide from $175/month, which makes it the fair comparison to run before you commit here.
What Claya dispenses
Claya prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product: the specific preparation has not been reviewed for safety, efficacy or manufacturing quality.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at Claya at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Safety and disclosure
Claya tells you its price before you start the medical questionnaire and that its pharmacy is accredited. We found no FDA warning letters issued to Claya. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Claya will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You care most about the twelve-month total, not the first bill. A flat-rate seller such as Collective will usually win that math.
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether Claya bills your plan before you start.
It fits if
- injections are the thing keeping you from starting
Our read
Claya costs more than the middle of this market, and the oral option is the clearest thing that premium buys. If the extras it charges for are ones you would actually use, that is a defensible trade. If not, the same molecule is available for less. Bodybuilding Health+ is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
Claya's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Before you pay Claya
Starting at $179 a month. Check today's price, then start the intake.
Where Claya is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Sesame Care.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare Claya head to head
The sellers closest to Claya on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Claya review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of June 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Claya's current pricing
Plans start at $179 a month. Whether you qualify is a clinician's decision, made after your intake.